nicardipine has been researched along with Atrial Fibrillation in 5 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elderly patients (n=340) who underwent radiofrequency ablation for atrial fibrillation were randomized into five groups: A, nicardipine; B nicardipine+esmolol; C, (nitroglycerin) group; D nitroglycerin+esmolol; E (control) groups." | 9.22 | Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial. ( Han, J; Liu, RC; Sun, DF; Sun, SH; Wang, LJ; Wu, Y; Yang, L, 2016) |
| "We investigated the potential role of increased plasma adrenomedullin and brain natriuretic peptide (BNP) levels in a patient with malignant hypertension." | 7.69 | Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. ( Ishikawa, K; Kangawa, K; Kawano, Y; Kitamura, K; Matsuo, H; Matsuoka, H; Nishikimi, T; Omae, T; Saito, Y; Yoshihara, F, 1996) |
| "Elderly patients (n=340) who underwent radiofrequency ablation for atrial fibrillation were randomized into five groups: A, nicardipine; B nicardipine+esmolol; C, (nitroglycerin) group; D nitroglycerin+esmolol; E (control) groups." | 5.22 | Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial. ( Han, J; Liu, RC; Sun, DF; Sun, SH; Wang, LJ; Wu, Y; Yang, L, 2016) |
| "We encountered a 91-year-old woman with atrial fibrillation complicating bradycardia while she was receiving therapy with an L/N-type calcium channel blocker, cilnidipine, for hypertension, which is an unusual observation for the dihydropyridine class of calcium channel blockers." | 3.73 | Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine. ( Ando, K; Hashimoto, K; Nakamura, Y; Satoh, Y; Sugiyama, A; Takahara, A, 2005) |
| "We investigated the potential role of increased plasma adrenomedullin and brain natriuretic peptide (BNP) levels in a patient with malignant hypertension." | 3.69 | Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. ( Ishikawa, K; Kangawa, K; Kawano, Y; Kitamura, K; Matsuo, H; Matsuoka, H; Nishikimi, T; Omae, T; Saito, Y; Yoshihara, F, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, SH | 1 |
| Yang, L | 1 |
| Sun, DF | 1 |
| Wu, Y | 1 |
| Han, J | 1 |
| Liu, RC | 1 |
| Wang, LJ | 1 |
| Sugiyama, A | 1 |
| Satoh, Y | 1 |
| Takahara, A | 1 |
| Ando, K | 1 |
| Nakamura, Y | 1 |
| Hashimoto, K | 1 |
| Raxwal, V | 1 |
| Gupta, K | 1 |
| Rüchardt, A | 1 |
| Eisenlohr, H | 1 |
| Lydtin, H | 1 |
| Nishikimi, T | 1 |
| Matsuoka, H | 1 |
| Ishikawa, K | 1 |
| Yoshihara, F | 1 |
| Kawano, Y | 1 |
| Kitamura, K | 1 |
| Saito, Y | 1 |
| Kangawa, K | 1 |
| Matsuo, H | 1 |
| Omae, T | 1 |
1 trial available for nicardipine and Atrial Fibrillation
| Article | Year |
|---|---|
Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Catheter Ablation; Cognitive Dysfunction; Female; Hear | 2016 |
4 other studies available for nicardipine and Atrial Fibrillation
| Article | Year |
|---|---|
Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine.
Topics: Aged; Analysis of Variance; Animals; Atrial Fibrillation; Bradycardia; Calcium Channel Blockers; Dih | 2005 |
Images in cardiovascular medicine. Coronary artery spasm.
Topics: Atrial Fibrillation; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Humans; Injections | 2006 |
[Myocardial involvement in carrier states for Duchenne muscular dystrophy. A rare cause of supraventricular arrhythmia].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fi | 1998 |
Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension.
Topics: Adrenomedullin; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; Echocardiography; Elec | 1996 |